WebApr 10, 2024 · SEATTLE, April 10, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the... WebJan 26, 2024 · SEATTLE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as …
News - Sana Biotechnology
WebJul 15, 2024 · Sana Biotechnology Inc. said in a Securities and Exchange Commission filing Wednesday that it signed a 10-year lease, with two additional five-year options, for the space in Pacific Commons... WebJan 26, 2024 · SEATTLE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application to initiate a first-in-human study of … michael dodsworth darlington
Sana Biotechnology - SANA Stock Forecast, Price & News
WebOct 30, 2024 · SEATTLE, Oct. 30, 2024 /PRNewswire/ -- Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today the acquisition of Oscine Corp., a... WebApr 12, 2024 · Goal to file IND for SC451 in 2024. SEATTLE, April 12, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that Science Translational Medicine has published a paper titled “Human hypoimmune primary … WebAn organised Researcher and Entrepreneur with over 3 years’ experience in Research, technical writing and a record of leading teams with high standards to achieve goals set. … michael dods rugby